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#Science: The Potential and the Challenges of Utilizing
Social Media and Other Electronic Communication
Platforms in Health Care
Violette Gijsen1,*, Michele Maddux2,3, Adam Lavertu4, Graciela Gonzalez-Hernandez5, Nilam Ram6, Byron Reeves7,8, Thomas Robinson8,
Victoria Ziesenitz9,10, Valentina Shakhnovich11,12 and Russ Altman13

Electronic communication is becoming increasingly popular worldwide, as evidenced by its widespread and rapidly growing use. In medicine, however, it remains a novel approach to reach out to patients. Yet, they have the potential for further
improving current health care. Electronic platforms could support therapy adherence and communication between physicians and patients. The power of social media as well as other electronic devices can improve adherence as evidenced by
the development of the app bant. Additionally, systemic analysis of social media content by Screenome can identify health
events not always captured by regular health care. By better identifying these healthcare events we can improve our current
healthcare system as we will be able to better tailor to the patients’ needs. All these techniques are a valuable component of
modern health care and will help us into the future of increasingly digital health care.
Electronic communication refers to the exchange of information by technological means, including the World Wide
Web, text and instant messaging, and social networking.1 It is becoming increasingly popular, as evidenced by
its widespread and rapidly growing use. As of March 31,
2017, world internet usage and population statistics were
at 4,346,561,853 internet users. It is also estimated that
15,220,700 texts are sent every minute of every day worldwide, with a median number of 60–100 daily texts per person,2 and, as of 2017, daily social media usage of global
internet users amounted to 135 minutes per day and global
social networking audiences surpassed 2 billion users in
2016.2,3
Despite worldwide usage of electronic communications
technology, it remains a novel approach used in medicine
to reach out to patients. With so many of us constantly connected to the internet, electronic communications could be
a great opportunity to tap into a popular mode of communication and connect with patients. For example, social media
could be used to improve medication adherence, or to identify health problems and adverse drug reactions that never
reach regulatory bodies or the physician’s office. Electronic
platforms could support therapy adherence and communication between physicians and patients. In this paper, we
will discuss the challenges and opportunities in utilizing
1

various forms of electronic communications for health care,
including research that has been done to date.
SOCIAL MEDIA AND ELECTRONIC PLATFORMS FOR
TREATMENT ADHERENCE: OPPORTUNITIES FOR
PATIENT ENGAGEMENT AND PATIENT CARE
Adherence is the extent to which a patient follows medical advice. Poor adherence to treatment regimens is a
significant problem across pediatric and adult populations. In fact, ~ 50% of children and adults with a chronic
illness are not taking enough of their prescribed medication.4 Nonadherence carries considerable implications
for morbidity and mortality, cost-effectiveness of medical care, and disease management decisions by healthcare providers. Poor adherence is also associated with
significantly poorer quality of life, impairments in psychosocial and physical functioning, greater absenteeism
from daily activities, and greater healthcare utilization.4,5
Many efforts have been spent toward developing multicomponent interventions to promote better adherence
in patients, with significant improvements in patient adherence. Yet, there is a paucity of information regarding social media use to monitor or improve medication
adherence.
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Social media may be a particularly appealing forum to target patient adherence. It capitalizes on a medium that many
patients already use and are familiar with, and has potential
to reach patients with limited healthcare access. Among the
few that have evaluated social media for patient adherence is
Scalzi et al.6 They evaluated an intervention aimed at improving medication adherence in adolescents with systemic lupus.
Participants were randomized to either answer questions
about the intervention in a journal or on a social media site,
where adolescents could discuss content of the educational
site with other adolescents with systemic lupus. Medication
adherence improved in both control and social media groups,
but the proportion of adherent patients improved significantly
only in the social media group. Similarly, an app called bant
was developed to improve self-management among adolescents with type 1 diabetes. This app allows youths to wirelessly transfer glucose readings, engage in a social community
with peers, and earn rewards for blood glucose readings. A
pilot test revealed that the daily average frequency of blood
glucose readings increased by 50% using the bant app.7 A
randomized clinical trial further confirmed a positive association between blood glucose readings and hemoglobin A1c
control using the app.8
Text messaging is another emerging electronic communication for enhancing treatment adherence. To date, texting
has been shown to increase attendance at medical appointments and to prompt administration of prescribed treatments. A meta-analysis regarding the use of text messaging
for improving medication adherence found a 20% increase
in patient adherence with 2-way text messaging (sending
reminders and requesting replies), but no effect with 1-way
text messaging (sending reminders only) highlighting specifically the advantage and the power of interactive electronic
platforms similar to social media.5
Other technical advances outside the use of social media
have contributed to better adherence as well. Electronic
platform monitors, devices that capture objective adherence
data, can provide more valid measures of adherence compared with self-reported estimates by patients. Electronic
monitors record the date and time a medication is removed
from the electronic device, and some have options for setting prompts when a medication is to be administered (e.g.,
alarms and text reminders). Electronic monitors are viewed
favorably by patients and have been used to provide feedback to patients about their medication-taking behaviors,
with noted significant improvements in adherence.9–12
SOCIAL MEDIA AS A TOOL TO CAPTURE ADVERSE
DRUG REACTIONS
Adverse drug reactions sit between the fourth and sixth
leading cause of death in the United States. According to
a systematic review of 25 observational studies, including 106,586 patients who were hospitalized, ~ 5.3% of
all hospital admissions around the world are associated
with adverse drug reactions (ADRs), with higher rates (a
median of 10.7%) reported for elderly patients.13 An earlier review of 39 studies had similar findings, calculating the overall incidence of serious ADRs at 6.7% of all

hospital admissions in the United States, with fatal ADRs
at 0.32%.14 Thus, the study estimated 106,000 fatal ADRs
nationally in 1994.
Due to the limitations of pre-approval clinical trials, it is
not possible to assess all of the ADRs associated with the
use of a particular drug before it is released, and spontaneous reporting of suspected ADRs by the public and
health professionals is essential for triggering signals
of drug safety.15 Research has exposed the inadequacies
of spontaneous reporting systems, particularly underreporting; it is estimated that only 6% of all ADRs are
reported,16 which delays the triggering of signals and, if
necessary, the corresponding action. The inadequacies
of self-reporting systems has prompted researchers and
regulatory agencies in charge of drug safety to explore
additional data sources for more effective ADR monitoring, such as electronic health records, claim forms, and,
relatively recently, social media.17
A systematic review from a pharmacology perspective
confirmed that reports of adverse events are identifiable
within social media and that the reports are generally consistent with what is known about the drugs in other sources
(such as drug labels or published trials). Some studies reported a higher frequency of adverse events in social media,
particularly for “symptom-related” and “mild” adverse
events.18
Whether the differences found between adverse events
reported in social media and those in traditional sources
genuinely reflect new adverse effects/reactions or more accurate frequencies of adverse effects/reactions is unknown.
What is clear is that social media can provide more complete information on adverse effects/reactions considered
important by patients, and aid researchers in understanding
patient perceptions.
Although there are still challenges, work in automatic
extraction of these data from social media and processing methods relevant to pharmacovigilance has advanced,
and it is indeed possible to extract these reports automatically.19 The potential for using social media for pharmacovigilance was envisioned relatively recently, with the
first pilot study published in 2010,20 with publications in
social media mining for pharmacovigilance growing significantly since around 2013. All the published studies between 2010 and 2014 took a lexicon-based approach to
finding adverse event expressions, a method that is inherently limited given that the variety of expressions present
in colloquial text are not typically present in lexicons. More
flexible approaches for extraction (machine-learning or
pattern based), such as ADRMine21 and Recurrent Neural
Network,22 are able to capture expressions not present in
a lexicon, but require an additional task to be addressed
in the aftermath of extraction of such expressions: normalization. Mapping them to standard terms so “my head is
being crushed by an elephant” is adequately identified as
a report of “migraine.”
Traditional approaches to the normalization problem used
in other health-related text miss relevant information when
applied to the colloquial language used in social media,23
given the amount of noise in the data and its unique level of
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creative license.24 Normalization models of user-generated
content (text messages) have proposed the use of various
error models, such as Hidden Markov Models25 and noisy
channel models.26
Purely lexical normalization of social media texts, such
as those from Twitter, have used similar approaches,27–29
focusing on correcting the irregularities of the text (misspellings, abbreviations, and such) to match to the lexicon. However, normalization of social media text is more
complex than correcting irregularities in the text. For example, ADRMine21 can find expressions, such as “make
my heart rate soar,” “I feel like my heart is gonna beat
out of my chest,” “heart-racy,” “heart rate off the charts,”
“heart beeping,” and “heart racing,” among the collected
postings and it can indicate that they are adverse effects
of albuterol. A lexical or dictionary match approach would
have missed all but “heart racing,” which is a concept
listed in the Unified Medical Language System (concept
ID C1868917). Mapping (normalizing) all of the other expressions to the Unified Medical Language System concept palpitations (C0030252) or the related heart racing
(C1868917) or heart pounding (C1868917) is a challenging
problem, and more creative normalization techniques that
synergize with the nature of social media (unsupervised
and semi-supervised approaches that “learn” from the
context of a mention) are needed. This can be highly significant in enabling pharmacovigilance and public health
research from social media.
Social media data used with other established sources
(the US Food and Drug Administration (FDA) adverse event
registration system data and drug insert data) can significantly help clinicians, regulators, and researchers identify
potential adverse effects that pose a threat to the public,
stimulate in-depth studies, and promote deeper understanding of the potential harms and public behaviors regarding the use of prescription drugs.
THE SCREENOME: INFERRING HEALTH BEHAVIORS
FROM COMPUTER SCREEN ACTIVITY
Prior to the invention of the internet and the proliferation
of smartphones, an individual’s interaction with the healthcare system was primarily limited to the clinical setting. The
advent of more mobile and accessible technologies has
disrupted the clinical paradigm, with individuals having unprecedented access to health information at the tip of their
fingers. That access can take many forms: search engines,
forums, and smartphone applications. Despite the broad
shift in how individuals manage their health in the modern
age, there has been limited work to characterize these interactions, with most of the literature primarily focused on
social media platforms, Facebook and Twitter, or patient
chatrooms. An ideal data set for studying digital behavior
needs to be high frequency, as the modern human-device
interaction lasts from ~ 10 seconds to 2 minutes, and passively/unobtrusively observed to avoid compliance and activity disruption issues.30,31
The primary means of communication between an individual and their device is through the device screen, thus
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screenshots represent a natural unit for data collection.
Screenomics is a framework for passive high frequency collection of digital device activity through screenshots.30 To
date, several cohorts have been recruited and installed applications on their smartphones and laptop computers that
recorded screenshots and metadata at 5-second intervals.
A key benefit of using screenshots as the unit of observation
is the ability to capture pan-application activity, rather than
having observation limited to a single platform, as with other
data sources. These screenshots were then encrypted and
uploaded to a cloud database and processed to extract text
via optical character recognition and assign activity labels
and other features.31
This framework results in a data set that preserves temporal information and contains rich high-resolution feature
content for further analysis. Thus, the Screenome captures
previously unobservable interactions between individuals
and digital health resources. Sequences of images within
the data demonstrate the nature of the modern digital health
landscape, especially the dynamic and heterogeneous nature of a user’s device interactions. Users are observed
accessing many different sources of information and/or avenues of communication related to health, even during a single interaction with the device. These interactions highlight
the potential of Screenome data to enable prevention, treatment, and management of various aspects of an individual’s
health.
The initial work using the Screenome has focused on
identifying human-device interaction sessions related to
health, the characterization of the health data sources
used by the public, and the interplay between drug and
disease interaction sessions. Future work with these data
could lead to methods for early detection of health-related
risks, passive postmarket surveillance for adverse drug
events and/or drug efficacy, and opportunities for precision interventions. There are many challenges posed by
these data, including reliable detection of health-related
content and determination of whether detected content is
indicative of the user’s health (vs. friends, family, or personal interest).
The initial analysis focuses on using the extracted text to
identify sessions related to diseases and drugs.30 Disease
and drug word groups were defined using word vectors
trained on a publicly available Reddit comment corpus. We
selected sets of two to three seed words for each category,
such as “diabetes” or “metformin.” The word groups were
then defined as the 200 semantically closest word (cosine
distance) for diseases and 50 closest words for drugs.31
After removing stop-words and non-words from the text
content of each screenshot, we computed counts of relevant words for each disease and drug category of interest.
Arranged with respect to time (Figure 1), these counts indicate when users interact with specific health-related content. Using eight initial drug and disease categories, pain,
diabetes, cancer, depression, and their associated drug
classes, we identified over 100,000 screenshots (of ~ 6 million) with non-zero scores for either drugs, diseases, or both.
This initial analysis demonstrates the presence of drug
and disease-related signals within Screenomes. Analysis of
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Figure 1 Diabetes and diabetes drugs text signal time-plot with screenshots related to a signal peak shown in sequence. The bottom
segment of the figure shows how the relevant word count in the screenshots changes across time in seconds (diabetes in purple,
and diabetes drugs in green). The top segment shows the series of screenshots associated with the signal peak, with black arrows
representing forward progress in time (~ 2–8 minutes).

these health-oriented device interaction sessions has the
potential to further our understanding of health information
seeking behavior in the digital age, across a heterogenous
collection of applications and websites, which is not possible with other data types.
CONCLUSION
For many years, the medical field has been struggling to
improve adherence and reduce adverse health events.
As discussed above, it is possible to harness the popularity and the power of social media and related, interactive, electronic devices to improve adherence by not
only reminding patients to take their medication but to
also give them actionable feedback in real time, opening
a direct line of communication among the patient, healthcare provider, and other peers facing similar obstacles
in treatment adherence. Additionally, systematic analysis
of social media content (e.g., by Screenome) can identify
adverse health events that are not always captured by

regulatory agencies and represent real-life patient experience that are relevant to health outcomes, behaviors,
and generalizable to public health. Beyond current technologies, research into the development of other digital
health tools through techniques like Screenome will continue to add to the momentum behind the digital health
movement. In conclusion, electronic communications
is declaring itself as a valuable component of modern
health care in this digital age.
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